Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Takeda turns its focus overseas

Japanese pharmaceutical company Takeda has bought Ariad Pharmaceuticals for around $5.2bn. Deals of this kind are becoming increasingly prevalent, as the Japanese pharma industry sets its sights beyond the traditional domestic market. Abi Millar reports.

Go Top